New Directions Technology Consulting helps clients develop innovative health and wellness programs.

New Directions Technology Consulting works with Fortune 500 companies, medium-sized companies and start-ups, as well as with trade and professional associations.

Current focus areas are medication telemanagement, advanced drug delivery systems and healthcare products information management (including remote track-and-trace), quality systems, and product regulations and standards.

New Directions is the exclusive market developer for the mMed patent portfolio, which relates to technology that takes medication telemanagement programs into "the wild," wherever mobile patients are. We are working to license or sell the intellectual property and/or partner to develop mobile medication telemanagement systems based on the patents. Managing Director Napoleon Monroe is the sole inventor of the patents.

As a subject matter expert and inventor of the mMed patent portfolio, Mr. Monroe can offer sale or licensing counsel related to developing systems based on the intellectual property.

Napoleon Monroe, managing director

Napoleon Monroe, Managing Director

Napoleon Monroe's diversified background extends from developing and producing emergency pharmaceutical delivery systems to managing private brands for a Fortune 500 company, to building and managing the IP portfolio for a company that is now part of Pfizer.

His expertise includes product development, licensing, regulatory processes, risk management and international marketing, with experience managing business relationships in more than 30 countries.

As vice president of corporate brand development for global healthcare distribution and service company Henry Schein, Inc., Mr. Monroe was responsible for all aspects of the company's private brands. He grew annual sales by more than 500 percent to more than $500 million. While there, he also began filing medication telemanagement patents.

Before Henry Schein, Mr. Monroe spent more than 20 years at Survival Technology (now a part of Pfizer), where, as a corporate vice president, he was responsible for product development and systems strategy. While at Survival, he invented three medical devices that were patented and commercialized; two were for auto-injectors and one was for a transtelephonic, peak-flow monitoring device.

Epipen Case Study
Applying the EpiPen Case Study

There, he also led teams that invented, prototyped, tested, commercialized and scaled up such products as: the EpiPen, still the leading product for treatment of anaphylactic shock; the Antidote Treatment Nerve Agent Auto-Injector delivery system, which still protects U.S. and allied military and civilian personnel; and products that supported the formation of Shahal Medical Services in Israel (acquired by Shanghai Jiuchuan) and Raytel (now part of Philips in the U.S.).

Mr. Monroe has been cited in such industry publications as PharmaVOICE. He is active in the Parenteral Drug Association, HIMSS, Prescription for a Healthy America, Health IT Now, National Defense Industrial Association and other groups. He is a longstanding member of the American Telemedicine Association. He supports East Carolina University where he did his undergraduate degree.



Mr. Monroe is a well known subject matter expert on medication telemanagement and a number of related topics. He regularly helps associations plan and host industry conferences, presents and moderates sessions at professional and trade conferences, co-writes and edits the newsletter for a trade association, comments regularly on legislation and regulations, and provides strategic and tactical advice to a wide range of commercial and not-for-profit organizations.

Media Highlights and Resources

New Directions Managing Director Napoleon Monroe in the News

Applying the EpiPen Case Study to Implementation of Smart Medication Telemanagement (SMT)

Drug Delivery Partnerships Blog (11-2-2015)


Pharmacy Podcast: Mobile Medication Management

Ron Lanton, with True North Political Solutions, interviews Monroe, covering many aspects of medication telemanagement, including some past failures and possible winners (3-4-2015)


mHealth: Patient Adherence Tools Get Personal

Monroe contributes to PharmaVOICE article (03-2014)


Track And Trace May Improve Patient Adherence

Monroe Explains to Pharmalot (7-15-2013)